Pathogenicity of newly isolated coxsackievirus B4 for mouse pancreas

Acta Virologica
|September 1, 1984
PubMed

Insights

Newly identified Coxsackievirus B4 strains from patients show varied pathogenicity. Some fecal isolates of Coxsackievirus B4 cause hypoglycemia in mice, suggesting distinct viral strains circulate in humans.

Area of Science:

  • Virology
  • Immunology
  • Pathogen research

Background:

  • Coxsackievirus B4 (CVB4) is associated with various human illnesses, including upper respiratory infections and aseptic meningitis.
  • Understanding the pathogenicity of different CVB4 strains is crucial for disease prevention and treatment.

Purpose of the Study:

  • To investigate the pathogenicity of fresh Coxsackievirus B4 isolates in a mouse model.
  • To determine if specific isolates can induce pancreatic dysfunction, leading to hypoglycemia.

Main Methods:

  • Fresh CVB4 isolates from patients with respiratory illness and meningitis were used.
  • SJL/J mice were inoculated with 12 different CVB4 isolates.
  • Blood glucose levels and clinical signs were monitored post-inoculation.

Main Results:

  • Seven out of 12 CVB4 isolates induced hypoglycemia in mice within 2-4 days.
  • All 3 isolates from fecal samples were pathogenic, causing hypoglycemia.
  • Isolates from cerebrospinal fluid did not induce hypoglycemia.
  • Four out of six throat swab isolates were pathogenic.

Conclusions:

  • At least two biologically distinct Coxsackievirus B4 strains appear to be prevalent in the human population.
  • Fecal shedding of CVB4 may indicate a higher pathogenic potential.
  • Further research is needed to understand the long-term pancreatic effects of CVB4 infection.

Related Concept Videos